Vergoeding 2020-2024 voor ATC-subgroep L04A : Immunosuppressiva
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| L04AA Selectieve immunosuppressiva | 15.701.700 | 14.839.000 | 20.046.300 | 26.355.200 | 29.811.100 |
| L04AD Calcineurineremmers | 38.533.200 | 32.928.400 | 34.321.800 | 35.587.100 | 37.234.600 |
| L04AE Sfingosine-1-fosfaat (s1p) receptormodulatoren | 25.316.200 | 27.894.900 | 32.729.400 | 31.350.300 | 28.347.200 |
| L04AF Jak-remmers | . | . | . | . | 356.380 |
| L04AG Monoklonale antilichamen | . | . | 1.525.100 | 5.724.200 | 9.842.200 |
| L04AH Mtor-kinaseremmers | 6.461.200 | 6.314.900 | 7.243.000 | 7.424.600 | 7.072.500 |
| L04AJ Complement remmers | . | . | . | . | 3.178.500 |
| L04AK Dhodh-remmers | 16.179.300 | 17.000.600 | 17.426.200 | 17.287.100 | 13.234.000 |
| L04AX Overige immunosuppressiva | 85.781.800 | 83.535.400 | 86.617.400 | 87.213.800 | 83.704.700 |
| Totaal | 187.973.400 | 182.513.200 | 199.909.200 | 210.942.300 | 212.781.180 |